The Structure looks good to us, waiting for this instrument to correct and then give us these opportunities as shown on this instrument (Price Chart). Note: Its my view only and its for educational purpose only. Only who has got knowledge about this strategy, will understand what to be done on this setup. its purely based on my technical analysis only...
Baxter International NYSE:BAX , a company that primarily focuses on products to treat kidney disease and other chronic and acute medical conditions, is another name that had a very rough time through 2022 and into 2024. However, the company's projected earnings and cash flow are expected to grow from 2024 through 2027 and it currently has a 3.35% dividend....
Key arguments in support of the idea ▪ Initial clinical data for CLN-619 are pending. Investment thesis Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing drugs for the treatment of cancer. On 1 June, Cullinan Therapeutics will present data from a Phase I clinical trial of its CLN-619 drug. The results of early-phase...
STAA is a medical company specialized in implantable lenses. Many of those needing lens replacements for cataracts put things off during the COVID era and eye surgeons are now catching up on backed up patient loads. Medical insurance companies are burdened with patients catching up from the covid delays for elective surgeries. The surgeons and medical...
MCK is a large cap medical supply company- it has experienced respectable earnings reports and steady growth as medical entities including surgery centers and hospitals are busy catching up on electric surgeries from the COVID era. It is rising ar or under the second upper VWAP line. The dual time frame RSI indicator ( by Chris Moody) shows that every time the...
The Medical Instruments and Supplies industry had stellar growth until 2022, when it could not beat that anomaly in revenue growth which was one of the primary reasons for the intermediate-term correction in 2022. 2023 patterned out the abnormal revenues and earnings for most industries that benefited from either the pandemic or from the government...
NYSE:MPW has pumped 19.60%+ today, and I received a great question about whether MPW has bottomed out. There was an opportunity to buy within the buy zone, and MPW had a strong rebound out of this buy zone. The momentum is currently bullish, and there is the possibility that MPW continues trending up towards the light blue trendline, which gives a price target...
LEXX on the daily chart is on a big bullrun breaking out of an ascending broadening triangle or megaphone pattern demostrative of increasing volatility. Retlative volumes are 2X the historical comparison. Price is now on the approach to the highs of 2023 but is only 15% of the all high highs of 19 at the neckline of a head and shoulders back in 2018-2019,...
While Cano Health Inc may be facing challenges, it's crucial to focus on the potential for recovery and growth. Use setbacks as stepping stones to success. The future holds opportunities for Cano Health to adapt and thrive in the ever-evolving healthcare landscape. Consider the current stock price under $3 as a potential entry point, but always conduct thorough...
Welltower is yet another Real Estate focused stock that I have been tracking in anticipation of its potential downside. Yesterday they had earnings and it was nothing that impressive, so I think the Bearish RSI Divergence at this PCZ will take over and bring it down to at least $53.40 to fill the downside gap from here
UNH after earnings with a mild beat in mid July, price shot up for one week then went sideways and then pulled back in the past week. Price is now at 497 and under the dynamic resistance of the first deviation line above the mean VWAP. The dual time frame shows a good pattern with the shorter TF of 3 minutes in green above the longer TF of 45 minutes in black....
BNTX a Germany company in the biotechnology and vaccine sectors out of Europe and Germany is looking good on the 2H chart here with a volume profile and an intermediate term VWAP overlaid. Price bounced off the bottom of the high volume area of the volume profile and looks to be ready for a reversion to the mean and even a sling-short move. The target here is...
ABT is Abbott Labs, a well-established medical technology company has had good earnings twice this year. In the first episode, the price trended down then recovered in a retracement. I have anchored a long-term mean VWAP and its standard deviations as a means to assess areas of dynamic support and resistance. One week ago, the price crossed the mean VWAP...
VYNE had a favorable earnings report last week. Fundamentally, analysts predict ( linked) approximately a doubling of the shart price in the next year. Like many low share priced biotechnology stocks the price is based on perceived future earnings which can be affected by favorable FDA process, or well-received research at industry conferences and changing...
VERO recently underwent a stock price 15:! split. Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. Its product portfolio consists of aesthetic device platforms which includes venus versa, venus legacy, venus velocity, venus...
ABT is shown on a 4H chart as setting up for a short trade. Demand and Summply Zones are charted by the LuxAlgo indicator. Price touched the supply zone five times in December- January then descended and touched the demand zone several times in mid-March. Fundamentally, earnings reports have been solid. Medical stocks are generally independent of the...
Hi, The market has made some pretty good moves up and the current slight correction is bringing prices back to technically good levels and Johnson & Johnson is one of them. Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer goods. Technically, it has been quite difficult...
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system...